According to a media report, the bank wants to expand its digital services into at least three new European countries.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Retail investors reassess growth favorites as Robinhood’s job cuts ripple through a market tilting toward industrial and financial stocks, today, June 16, 2026.
Procter & Gamble (NYSE:PG) is the household name every retirement portfolio reaches for when markets get choppy, and its $350.4 billion market cap makes it the default consumer defensive trade on every desk. The internals tell a different story. The Crowded Trade Is Quietly Cracking P&G beat its most recent quarter, but the internals are ... Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today
The online brokerage still has plenty of upside potential.
Both Nvidia and Alphabet have big chip opportunities ahead.
Oracle stock may have underperformed the market over the past year, but it could deliver terrific gains by accelerating the conversion of its massive backlog into revenue.
At $80.91, Coca-Cola (NYSE:KO) sits in a holding pattern. Shares have rallied roughly 23% off the 52-week low and now trade where high risk-free Treasury yields are squeezing defensive staple multiples. Coca-Cola is the largest nonalcoholic beverage system in the world, anchored by sparkling soft drinks and increasingly carried by double-digit volume growth in Coca-Cola ... Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock
It could be a great move by the billionaire hedge fund manager.
For income investors weighing biopharma exposure, the dividend question on AbbVie (NYSE:ABBV) just got a lot easier to answer. The company posted $15.002 billion in Q1 2026 revenue, beating consensus by $284 million, and management raised full-year adjusted EPS guidance to $14.08 to $14.28. With the stock yielding nearly 3%, the question is whether the ... This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie
Tesla and SpaceX are all-in on building a massive semiconductor manufacturing capability, and that's great news for the European company.

While SpaceX (SPCX) holds onto stock gains in Tuesday's session, the options market has been abuzz today as more traders chase options contracts on the space company. YieldMax ETFs chief strategist Mike Khouw comes on Market Domination to speak more about what retail investors should beware of when hopping into options trades on a company fresh off of its IPO.
Rackspace inked a data center deal with Advanced Micro Devices.
For the past six months, XRP (CRYPTO:XRP) slid lower as the Iran war battered the whole market, and plenty of holders gave up and sold. However, the biggest holders did the exact opposite. Wallets holding a million coins or more now own almost three-quarters of all the XRP in existence, and they did that by ... XRP Holders With 1 Million Coins Now Own 74% of the Supply
After hitting an all-time high in November last year, this fintech stock has traded down 47%.
Yahoo Finance Markets & Data Editor Jared Blikre tracks SpaceX's (SPCX) historic rise following its IPO debut on Friday. The aerospace giant has been on a meteoric run, jumping to become the fourth-largest company in the world by market capitalization as investors pile into one of the market's most closely watched new listings.
Massachusetts startup Phoenix Tailings — backed by BMW and Sumitomo — is undertaking the project.
It could go both ways, actually.
HPE played up a one-two punch in the emerging AI market, recently acquired Juniper Networks playing a big part in its strategy.
Amazon and Alphabet look like much better buys today.
Moderna (NASDAQ:MRNA) stock is jumping again. Shares are up 9% today, trading near $57 in the Tuesday afternoon session. That extends a remarkable 2026 run for the mRNA pioneer. The move pushes Moderna stock to +94% year to date (YTD), easily the best performance in the major vaccine cohort. By comparison, Pfizer (NYSE:PFE) stock is ... Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Cornelis networking chips will connect computers in a U.S. nuclear-research supercomputer.
Jerome Powell just issued a stark warning about the future of the Federal Reserve -- and the implications for your portfolio could be enormous.
NEOS Nasdaq-100 High Income ETF (NASDAQ:QQQI) offers a roughly 13.8% distribution yield, paid monthly, on a portfolio holding NVIDIA, Apple, and Microsoft. For income investors tired of 4% Treasuries and 2% dividend funds, QQQI looks like a cheat code. The question is whether that headline yield is durable income or partly a refund of your ... QQQI’s 13.8 Percent Monthly Yield Comes With a Hidden Cost Most Income Investors Miss
Micron Technology Inc (NASDAQ:MU) is one of billionaire Ken Fisher’s top high growth stock picks. Micron has emerged as one of investors’ favorite semiconductor stocks amid the AI boom. The stock has surged more than 196% year-to-date and exploded 720% over the past year. Micron Technology Inc (NASDAQ:MU) has been approved to supply HBM4 memory […]
Nvidia Corp (NASDAQ:NVDA) is one of billionaire Ken Fisher’s top high growth stock picks. Nvidia shares have gained more than 10% year-to-date and soared more than 45% over the past year. Analysts expect the stock to keep rising, forecasting nearly 50% upside to the current price. On June 7, Nvidia Corp (NASDAQ:NVDA) announced a large […]
Investors looking for 2x daily exposure to gold typically land on two tickers: DB Gold Double Long ETN (NYSEARCA:DGP) and ProShares Ultra Gold (NYSEARCA:UGL). On a one-day basis they move almost in lockstep, both up roughly 7.4% and 7.1% respectively in today’s session. The real distinction sits beneath the ticker: one is a senior unsecured ... DGP vs. UGL: Which 2x Gold Play Costs You More Than the Leverage?
Even if you have only a modest amount of money to invest, any one of these funds provides the diversified, broad market coverage to serve as the core of your portfolio.